You are in a distributor managed country, to make orders please contact your local distributor
Contact Distributor
×
Learn more
Webcast featuring eSpOT-ON
Explore More
eSpOT-ON Nuclease Protein Available Now
Explore More
Order eSpOT-ON Nuclease mRNA Now
Cart
Account
Your Orders
Sign Out
Sign In
My Cart
Products
CRISPR GENE EDITING
Research gRNAs
gRNA Controls
CRISPR GENE EDITORS
eSpOT-ON Protein
eSpOT-ON mRNA
AccuBase™ Base Editor
hfCas12Max Nuclease
Research SpCas9
cGMP MANUFACTURING
GMP gRNA
GMP CRISPR Editors
Regulatory Expertise
MOLECULAR Dx
PCR & RT Enzymes & Products
IVT Enzymes
Isothermal Amplification
Sample Preparation & Processing
Custom Manufacturing
Solutions
CRISPR GENE EDITING
Explore CRISPR Continuum
CRISPR Clinical Solutions
CRISPR Nucleases
Regulatory Expertise
MOLECULAR Dx
Revolutionize Molecular and Clinical Diagnostics
Essential IVT Enzymes
DESIGN & ANALYSIS
Explore CRISPR Design Tools
ICE CRISPR Analysis Tool
Learn
CRISPR GENE EDITING
What Is CRISPR
How To Use CRISPR Guide
CRISPR Methods
Other Genome Editing Tools And Applications
Base Editing
CAR-T Cell Therapy
CRISPR in iPS Cells
MOLECULAR Dx
RT-RPA Guide
RPA Guide
Reverse Transcription Guide
RESOURCE LIBRARY
Protocols
Application Notes
Case Studies
Videos
eBooks
Publications
FROM THE BENCH
Company
About
Newsroom
Careers
Partner With Us
Testimonials
Support
Help
Protocols
Contact
Order
Research sgRNA
hfCas12Max Nuclease
SpCas9 Nuclease
gRNA Controls
Your Account
Cart
Account
Edit Credit
Your Orders
Sign In
Sign Out
Contact Sales
Newsroom
Stay Connected with Our Latest News and Media Assets
Contact Us
Download Synthego Logo
Showing 12 of 107
Synthego Announces Entry into Molecular Biology and Clinical Diagnostic Reagents Market
Jan 13, 2026
Synthego Launches High-Performance Molecular Reagents for Clinical and Molecular Diagnostics
Nov 10, 2025
Synthego Announces Successful Close of Acquisition by Perceptive Advisors
Jul 21, 2025
Synthego Gains Approval to Proceed with Sale to Perceptive Advisors; Transaction Set to Close in July
Jun 26, 2025
Synthego Prevails In Patent Appeal Confirming Agilent CRISPR Patents Are Invalid
Jun 12, 2025
Synthego Introduces GMP SpCas9 to Accelerate Gene Editing for Therapeutic Advancement
May 12, 2025
Synthego Initiates Strategic Financial Restructuring to Facilitate Sale, Reduce Debt, Strengthen Balance Sheet
May 5, 2025
Synthego and Vita Therapeutics Announce Strategic Licensing Agreement for hfCas12Max CRISPR Nuclease
Apr 8, 2025
AstraZeneca, Synthego ink gene editing enzyme licensing deal
Jan 13, 2025
Synthego Signs Strategic Agreement with AstraZeneca to License CRISPR Gene Editing Enzyme eSpOT-ON
Jan 13, 2025
Synthego Launches High-Value IVT Enzymes for Advanced RNA Therapeutics
Nov 4, 2024
Synthego Launches hfCas12Max High-Fidelity CRISPR Enzyme for Therapeutic Development
Jun 3, 2024
Cart
Account
Your Orders
Sign Out
Sign In